These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22020288)

  • 41. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
    Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists.
    Bray JK; Goddard WA
    J Mol Graph Model; 2008 Aug; 27(1):66-81. PubMed ID: 18499489
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of the binding sites and selectivity of sarpogrelate, a novel 5-HT2 antagonist, to human 5-HT2A, 5-HT2B and 5-HT2C receptor subtypes by molecular modeling.
    Rashid M; Manivet P; Nishio H; Pratuangdejkul J; Rajab M; Ishiguro M; Launay JM; Nagatomo T
    Life Sci; 2003 May; 73(2):193-207. PubMed ID: 12738034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists.
    Hansen M; Jacobsen SE; Plunkett S; Liebscher GE; McCorvy JD; Bräuner-Osborne H; Kristensen JL
    Bioorg Med Chem; 2015 Jul; 23(14):3933-7. PubMed ID: 25583099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ACS chemical neuroscience molecule spotlight on Lorcaserin.
    Hopkins CR
    ACS Chem Neurosci; 2010 Nov; 1(11):718-9. PubMed ID: 22778808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Site-directed mutagenesis of the serotonin 5-Hydroxytryptamine2c receptor: identification of amino acids responsible for sarpogrelate binding.
    Muntasir HA; Takahashi J; Rashid M; Ahmed M; Komiyama T; Hossain M; Kawakami J; Nashimoto M; Nagatomo T
    Biol Pharm Bull; 2006 Aug; 29(8):1645-50. PubMed ID: 16880620
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of 5-HT(2C) mediated mechanisms involved in urethral sphincter reflexes in a guinea-pig model of urethral function.
    Conlon K; Miner W; McCleary S; McMurray G
    BJU Int; 2012 Jul; 110(2 Pt 2):E113-7. PubMed ID: 22192599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential effects of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone (SB 243213) on 5-hydroxytryptamine(2C) receptor-mediated responses.
    Berg KA; Navailles S; Sanchez TA; Silva YM; Wood MD; Spampinato U; Clarke WP
    J Pharmacol Exp Ther; 2006 Oct; 319(1):260-8. PubMed ID: 16807362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N; Ebersole BJ; Ballesteros JA; Weinstein H; Sealfon SC
    Mol Pharmacol; 1996 Jul; 50(1):34-42. PubMed ID: 8700116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different regulation of rat 5-HT(2A) and rat 5-HT(2C) receptors in NIH 3T3 cells upon exposure to 5-HT and pipamperone.
    Oekelen DV; Jurzak M; Van de Wiel D; Van Hecke G; Luyten WH; Leysen JE
    Eur J Pharmacol; 2001 Aug; 425(1):21-32. PubMed ID: 11672571
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
    Fantegrossi WE; Simoneau J; Cohen MS; Zimmerman SM; Henson CM; Rice KC; Woods JH
    J Pharmacol Exp Ther; 2010 Dec; 335(3):728-34. PubMed ID: 20858706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential modes of agonist binding to 5-hydroxytryptamine(2A) serotonin receptors revealed by mutation and molecular modeling of conserved residues in transmembrane region 5.
    Shapiro DA; Kristiansen K; Kroeze WK; Roth BL
    Mol Pharmacol; 2000 Nov; 58(5):877-86. PubMed ID: 11040033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. Endogenous 5-HT(2C) receptors in choroid plexus epithelial cells.
    Chang M; Zhang L; Tam JP; Sanders-Bush E
    J Biol Chem; 2000 Mar; 275(10):7021-9. PubMed ID: 10702266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discriminative stimulus effects of serotonin agonists, neutral antagonists, and inverse agonists in pigeons: perspectives on intrinsic efficacy measurements in vivo.
    Farrell M; Rosenzweig-Lipson S; Walker E
    Psychopharmacology (Berl); 2010 Aug; 211(2):149-59. PubMed ID: 20526585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo evaluation of [
    Prabhakaran J; Solingapuram Sai KK; Zanderigo F; Rubin-Falcone H; Jorgensen MJ; Kaplan JR; Tooke KI; Mintz A; Mann JJ; Kumar JSD
    Bioorg Med Chem Lett; 2017 Jan; 27(1):21-23. PubMed ID: 27889455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction.
    Herrick-Davis K; Grinde E; Niswender CM
    J Neurochem; 1999 Oct; 73(4):1711-7. PubMed ID: 10501219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antiallodynic effects of intrathecally administered 5-HT(2C) receptor agonists in rats with nerve injury.
    Obata H; Saito S; Sakurazawa S; Sasaki M; Usui T; Goto F
    Pain; 2004 Mar; 108(1-2):163-9. PubMed ID: 15109520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
    Zaniewska M; McCreary AC; Wydra K; Filip M
    Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lorcaserin: an investigational serotonin 2C agonist for weight loss.
    Hurren KM; Berlie HD
    Am J Health Syst Pharm; 2011 Nov; 68(21):2029-37. PubMed ID: 22011982
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Further pharmacological characterization of 5-HT(2C) receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo.
    Quérée P; Peters S; Sharp T
    Br J Pharmacol; 2009 Nov; 158(6):1477-85. PubMed ID: 19845681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.